CollPlant Biotechnologies Ltd.
  • About
    • About Us
    • Management Team
    • Board of Directors
    • Advisory Board
    • Partnering
  • Technology
    • rhCollagen
    • 3D Bioprinting
  • Product Pipeline
    • Collink.3D Bioinks
    • Gut-on-a-Chip
    • Medical Aesthetics
      • Dermal Fillers
      • Breast Implants
    • Vergenix products
  • Investors
    • Overview
    • News & Events
    • Company Info
    • Financial Info
    • Stock Data
    • SEC Filings
    • Governance
  • Media Room
    • Publications
    • Posters and Presentations
    • Media Coverage
    • Videos
  • Contact
    • Contact us
    • Careers
search

Press Releases

Investors

Investors

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • Events
    • Email Alerts
  • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
    • Board Diversity Matrix
  • News & Events

  • Overview
  • Press Releases
  • Events
  • Email Alerts
Feb 19, 2019 6:00am EST

CollPlant Announces Approval of Its rhCollagen Manufacturing Facility by European Union Notified Body

Dec 10, 2018 9:04am EST

Clinical Trial Published in the Journal of Shoulder and Elbow Surgery Concludes That CollPlant's Vergenix™ STR Effectively Demonstrates Significant Clinical Improvements in Tennis Elbow

Nov 29, 2018 8:07am EST

CollPlant Reports Third Quarter 2018 Financial Results and Provides Business Update

Nov 12, 2018 6:00am EST

CollPlant Announces Closing of Global Licensing and Commercialization Agreement With United Therapeutics for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants

Nov 07, 2018 10:00am EST

CollPlant to Ring Nasdaq Opening Bell on November 8, 2018

Oct 28, 2018 8:00am EDT

CollPlant Shares Will Be Traded From Tuesday Oct 30 Exclusively on Nasdaq

Oct 22, 2018 4:00am EDT

CollPlant and United Therapeutics Announce Global Licensing and Commercialization Agreement for 3D Bioprinting of Solid-Organ Scaffolds for Human Transplants

Sep 21, 2018 4:10pm EDT

CollPlant Reports Second Quarter 2018 Financial Results and Provides Business Update

Aug 28, 2018 7:00am EDT

CollPlant Holdings to Present at the 20th Annual Rodman & Renshaw Global Investment Conference

Aug 08, 2018 9:00am EDT

Dual-Listed CollPlant to Voluntarily Delist From Tel Aviv Stock Exchange

RSS
  • Prev
    • 1...
    • 5
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    Next
    • Email Alerts
    • Tear Sheet
    • Contacts
    • RSS News Feed

    Details

    exploreCollPlant Ltd

    4 Oppenheimer Street
    P.O. Box 4132
    Rehovot 7670104, Israel

    LinkedinLinkedIn YoutubeYoutube TwitterTwitter
    local_phone+972 73 2325600
    local_printshop+972 73 2325602
    mailinfo@collplant.com

     
     

    ® 2023 CollPlant Biotechnologies Ltd. All rights reserved. Version: CPW 02-20